AIG
KLDO

American International Group’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

American International Group’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,618
Closed -$16K – 3400
2022
Q1 		$16K Sell
9,618
-676
-7% -$1.21K ﹤0.01% 3053
2021
Q4 		$25K Sell
10,294
-309
-3% -$1.26K ﹤0.01% 3072
2021
Q3 		$58K Sell
10,603
-251
-2% -$1.56K ﹤0.01% 2966
2021
Q2 		$81 Buy
10,854
+2,893
+36% +$20.5K ﹤0.01% 2922
2021
Q1 		$64 Buy
7,961
+1,138
+17% +$12.4K ﹤0.01% 2917
2020
Q4 		$62 Sell
6,823
-112
-2% -$919 ﹤0.01% 2891
2020
Q3 		$77K Buy
6,935
+865
+14% +$5.99K ﹤0.01% 2667
2020
Q2 		$45K Sell
6,070
-654
-10% -$4.38K ﹤0.01% 2918
2020
Q1 		$41K Sell
6,724
-390
-5% -$2.54K ﹤0.01% 2765
2019
Q4 		$36K Buy
7,114
+3,928
+123% +$25K ﹤0.01% 2951
2019
Q3 		$24K Sell
3,186
-21
-0.7% -$182 ﹤0.01% 3006
2019
Q2 		$37K Buy
+3,207
New +$46.7K ﹤0.01% 3004

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

American International Group's KLDO Position: Q2 2022 in Review

American International Group sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 9,618 shares — an estimated $16K sold.

American International Group first reported a position in KLDO in Q2 2019 and held it in 12 quarters. The position peaked at $77K in Q3 2020. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • American International Group reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 9,618 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $16K.
  • American International Group first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • American International Group's Kaleido Biosciences, Inc. Common Stock position peaked at $77K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.